Will 68Ga-PSMA PET become the New Imaging Standard for Prostate Cancer?

被引:0
|
作者
Duewel, C. [1 ]
Eiber, M. [2 ]
Maurer, T. [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Urol Klin & Poliklin, Ismaninger Str 22, D-81671 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Nukl Med Klin & Poliklin, Munich, Germany
关键词
PSMA; prostate cancer; PET; staging; recurrence; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; GA-68-LABELED PSMA LIGAND; BIOCHEMICAL RECURRENCE; DIAGNOSIS; BIOPSY;
D O I
10.1055/s-0042-110982
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This article describes the current knowledge in prostate cancer imaging with Ga-68-PSMA PET, which achieves excellent specificities and higher sensitivities compared with standard imaging for local tumour detection as well as primary and recurrence staging. Therefore, Ga-68-PSMA PET will probably play an increasing role for the diagnostic investigation of prostate cancer and will be more widely used in the future.
引用
收藏
页码:378 / 382
页数:5
相关论文
共 50 条
  • [41] 68Ga-PSMA PET/CT in Biochemical Relapsed Prostate Cancer Initial Experience
    Silva, R.
    Abrunhosa, A.
    Figueiredo, A.
    Cruz, A.
    Xavier, A.
    Barroca, D.
    Castelo Branco, M.
    Pedroso de Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S336 - S336
  • [42] Evaluation of 68Ga-PSMA PET/CT in patients with Biochemical Recurrence of Prostate Cancer
    Dyankova, M.
    Stoeva, T.
    Dancheva, Z.
    Yordanova, T.
    Chausheva, S.
    Chaushev, B.
    Klisarova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S450 - S451
  • [43] 68Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer
    Matthias Eiber
    Stephan G. Nekolla
    Tobias Maurer
    Gregor Weirich
    Hans-Jürgen Wester
    Markus Schwaiger
    Abdominal Imaging, 2015, 40 : 1769 - 1771
  • [44] The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer
    Demirkol, Mehmet Onur
    Kiremit, Murat Can
    Acar, Omer
    Ucar, Burcu
    Saglican, Yesim
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (05) : 403 - 405
  • [45] 68Ga-PSMA PET/CT in prostate cancer patients - normal variants and pitfalls
    Keidar, Zohar
    Gill, Rona
    Goshen, Elinor
    Pirmisashvili, Natalia
    Israel, Ora
    Morgulis, Maryna
    Ben-Haim, Simona
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [46] The impact of dual time point 68Ga-PSMA PET/CT imaging on PSMA uptake of primary tumor in prostate cancer
    Simsek, D. Has
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S460 - S460
  • [47] Comparison of 68Ga-PSMA PET/CT and MRI in evaluating the lateralization of prostate cancer
    Wang, M.
    Quan, Z.
    Zhao, X.
    Han, T.
    Meng, X.
    Kang, F.
    Wang, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S495 - S495
  • [48] Myelofibrosis Pattern in 68Ga-PSMA PET/CT of a Patient With Recurrence Prostate Cancer
    Kunikowska, Jolanta
    Pelka, Kacper
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (02) : E182 - E183
  • [49] Immunohistochemical Validation of PSMA Expression Measured by 68Ga-PSMA PET/CT in Primary Prostate Cancer
    Woythal, Nadine
    Arsenic, Ruza
    Kempkensteffen, Carsten
    Miller, Kurt
    Janssen, Jan-Carlo
    Huang, Kai
    Makowski, Marcus R.
    Brenner, Winfried
    Prasad, Vikas
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (02) : 238 - 243
  • [50] Hybrid 68Ga-PSMA PET-CT for primary prostate cancer staging
    Lee, J.
    BJU INTERNATIONAL, 2017, 119 : 55 - 56